1 / 6

Pharmacogenomics (PGx) Market Growth Opportunities, Industry Analysis, Size 2020

Pharmacogenomics (PGx) Market

swati15
Télécharger la présentation

Pharmacogenomics (PGx) Market Growth Opportunities, Industry Analysis, Size 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacogenomics (PGx) market To Reach USD 11.01 billion By 2027 www.reportsanddata.com

  2. Market Summary he global pharmacogenomics (PGx) market is forecast to reach USD 11.01 billion in 2027, according to a new report by Reports and Data. The global pharmacogenomics (PGx) market is growing at a substantial pace owing to the growing demand for personalized therapy, increasing prevalence of target chronic diseases, technological advancements, favorable government initiatives, availability of financial support for research and development. Pharmacogenomics has high demand; therefore, research centers invest a handful of the amount in their R&D, which fuels up the market growth by a large margin. Further key findings from the reportsuggest The pharmacogenomics (PGx) market is anticipated to be dominated by the North American region. The major driving factors for the growth of this market are because of rising demand of personalized medicines, high medical reimbursement facilities, and technological advancement. The softwares are expected to have the largest market share among the other segments. This is attributed to the widespread application of genomic data to effectively influence healthcare outcomes. The testing methods are improved and the public and health care professionals are educated about the potential benefits owing to the technologicaladvancements. • • www.reportsanddata.com

  3. Market Summary KeyPlayers: Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory Corporationof America Holdings. Segmentation: Product Type Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2016-2026) Kits Assay & Reagents Instruments Application Type Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2016-2026) Oncology Infectious Diseases Neurology/Psychiatry Cardiovascular Read More: https://www.reportsanddata.com/report-detail/pharmacogenomics-pgx-market www.reportsanddata.com

  4. Market Summary End-Users Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2016-2026) Research Organisation Pharmaceutical Companies Diagnostic Centers Regional Outlook for Artificial Intelligence (AI) in Construction Market analyses the following geographies: North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) www.reportsanddata.com

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  6. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related